Role of Molecular Agents and Targeted Therapy in Clinical Trials for Women With Ovarian Cancer
Jonathan A Ledermann, Christian Marth, Mark S Carey, Michael Birrer, David DL Bowtell, Stan Kaye, Iain McNeish, Amit Oza, Giovanni Scambia, Gordon Rustin, Frederick B Stehman, David Gershenson, Gillian Thomas, Els Berns, Antonio Casado, Nelleke Ottevanger, Felix Hilpert, Byoung-Gie Kim, Aikou Okamoto, Monica Bacon Show all
International Journal of Gynecologic Cancer | BMJ PUBLISHING GROUP | Published : 2011
Awarded by Medical Research Council
The 4th Ovarian Cancer Consensus Conference was convened by the GCIG in Vancouver, BC, Canada from June 24th-28th, 2010. Unrestricted grants were gratefully received for support of this conference from Astra Zeneca, Roche, GlaxoSmithKline, Pharmamar, Ortho Biotech, Boehringer Ingelheim, Canadian Cancer Society Research Institute, Ovarian Cancer Canada, National Cancer Institute (US), Taiho, Merck, Pfizer, and Amgen. The agenda, deliberations and final statements were developed entirely by the GCIG with no involvement from the funding sources.